mapracorat ophthalmic suspension

mapracorat · Bausch & Lomb Incorporated

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for mapracorat ophthalmic suspension, covering 2020-09-03 to 2020-09-03. Get the full timeline:

Most recent: Clinical Trial Update: Mapracorat Ophthalmic Suspension for the Treatment of Ocular Inflammation Following Cataract Surgery [Phase 3]